Detalhe da pesquisa
1.
UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant Exposure.
Cancer Chemother Pharmacol
; 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38305868
2.
Applications of Advanced Natural Language Processing for Clinical Pharmacology.
Clin Pharmacol Ther
; 115(4): 786-794, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38140747
3.
The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodies.
CPT Pharmacometrics Syst Pharmacol
; 12(5): 639-655, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36752286
4.
From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy.
Clin Pharmacol Ther
; 113(5): 963-972, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282521
5.
Concentration QTc analysis of giredestrant: Overcoming QT/heart rate confounding in the presence of drug-induced heart rate changes.
Clin Transl Sci
; 16(5): 823-834, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36772881
6.
Establishment of a Disease-Drug Trial Model for Postmenopausal Osteoporosis: A Zoledronic Acid Case Study.
J Clin Pharmacol
; 60 Suppl 2: S86-S102, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274518
7.
Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.
Perit Dial Int
; 40(4): 384-393, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32065053
8.
Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim.
Front Pharmacol
; 11: 868, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32595502
9.
Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment.
Clin Pharmacol Drug Dev
; 4(5): 326-36, 2015 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27137141